Turnstone Biologics Corp [TSBX] stock prices are up 10.71% to $0.35 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TSBX shares have gain 4.25% over the last week, with a monthly amount drifted -1.09%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Turnstone Biologics Corp [NASDAQ: TSBX] stock has seen the most recent analyst activity on February 05, 2025, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $0.40 from $3.75. Previously, BofA Securities downgraded its rating to Underperform on November 15, 2024. On October 14, 2024, downgrade downgraded it’s rating to Neutral. SVB Securities started tracking the stock assigning a Market Perform rating. Piper Sandler initiated its recommendation with a Overweight and recommended $20 as its price target on August 15, 2023. BofA Securities started tracking with a Buy rating for this stock on August 15, 2023, and assigned it a price target of $18.
The stock price of Turnstone Biologics Corp [TSBX] has been fluctuating between $0.29 and $3.05 over the past year. Currently, Wall Street analysts expect the stock to reach $0.5 within the next 12 months. Turnstone Biologics Corp [NASDAQ: TSBX] shares were valued at $0.35 at the most recent close of the market. An investor can expect a potential return of 42.86% based on the average TSBX price forecast.
Analyzing the TSBX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -2.28, Equity is -1.63 and Total Capital is -3.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2977 points at the first support level, and at 0.2491 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3874, and for the 2nd resistance point, it is at 0.4285.
Ratios To Look Out For
It’s worth pointing out that Turnstone Biologics Corp [NASDAQ:TSBX]’s Current Ratio is 3.70. As well, the Quick Ratio is 3.70, while the Cash Ratio is 3.01.
